Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Protein Folding 09: Sickle Cell Disease
Sickle cell disease affects ~70,000 to 100,000 people in the United States, and ~10 million worldwide. The disease was first described by James B. Herrick [Herrick 1910]. The molecular basis was partly elucidated by Linus Pauling and Ibert C. Wells [Pauling 1949], and the exact causal amino acid substitution (E6V) was later identified by V.M. Ingram [Ingram 1956]. This missense variant causes hemoglobin to form long polymers which deform red blood cells into a “sickle” shape.
+myBinderRelated Content
-
Reduced fitness and abnormal cardiopulmonary responses to maximal exercise testing in children and young adults with...Physiologic contributors to reduced exer...
-
Sickle Cell Disease: Racism in the American Health Care SystemWednesday, June 28 1-4 pm EDT Massachu...
-
Health-related quality of life at 1 Year in the drepagreffe trial comparing chronic transfusion to transplantation i...Health is not just defined as the absenc...
-
Got TransitionGot Transition/Center for Health Care Tr...
-
Rita Paschal, MDDr. Paschal is Associate Professor of me...
-
Statement on NHLBI Decision to Pause the Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for Si...bluebird bio, Inc. suspended its clinica...
-
2019 WEPSCF Rockin’ the Red – 14th Annual FundraiserJoin us as we celebrate National Sickle ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
